Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,586
New position
Shares Held
183
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#359
of 421 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ACTION POINT FINANCIAL PLANNING, LLC holds $163,523 across 25 Drug Manufacturers - Specialty & Generic names. ALKS ranks #7 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
57 | $30,877 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
1,484 | $21,500 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
137 | $15,194 | |
| 4 | VTRS |
Viatris Inc
|
858 | $13,622 | |
| 5 | HLN |
Haleon plc
|
1,197 | $11,164 | |
| 6 | EBS |
Emergent BioSolutions Inc.
|
1,308 | $10,960 | |
| 7 | ALKS |
Alkermes plc.
This page
|
183 | $9,586 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
382 | $9,397 |
All Filings in ALKS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,586 | 183 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||